BioCentury
ARTICLE | Clinical News

NeoRx reports Phase I/II data

July 11, 2000 7:00 AM UTC

NERX reported data from a study of its skeletal targeted radiotherapy (STR) to treat multiple myeloma. Of 56 evaluable patients, 3 maintained complete remission (CR), 20 improved to CR status, 4 had p...